Organization and Basis of Presentation (Details) $ / shares in Units, $ in Thousands		3 Months Ended
	Apr. 04, 2022 USD ($) shares	Mar. 31, 2023 USD ($) segment $ / shares	Apr. 01, 2022 USD ($)	Dec. 31, 2022 USD ($)	Nov. 30, 2022 shares
Concentration Risk [Line Items]
Number of reportable segments | segment		2
Quarterly cash dividend declared (in dollars per share) | $ / shares		$ 0.05
Payment of dividends		$ 3,033	$ 0
Net income		31,903	55,437
Cumulative translation loss		(1,419,585)		$ (1,350,207)
Research and development expense		9,600	$ 9,500
Foreign Currency Translation Adjustment
Concentration Risk [Line Items]
Cumulative translation loss		100,000
Enovis Corporation
Concentration Risk [Line Items]
Number of shares sold | shares					6,000,000
Russia
Concentration Risk [Line Items]
Net income		$ 2,000
Russia | Assets | Geographic Concentration Risk
Concentration Risk [Line Items]
Concentration risk (as a percent)		4.00%
Russia | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Concentration Risk [Line Items]
Concentration risk (as a percent)		5.00%
Enovis Corporation
Concentration Risk [Line Items]
Cash consideration	$ 1,200,000
ESAB Corporation | Enovis Corporation
Concentration Risk [Line Items]
Ownership (as a percent)	10.00%
Common Stock
Concentration Risk [Line Items]
Percentage of outstanding stock after spin-off (as a percent)	90.00%
Common Stock | Enovis Corporation
Concentration Risk [Line Items]
Number of shares recapitalized (in shares) | shares	3
Common Stock | ESAB Corporation | Enovis Corporation
Concentration Risk [Line Items]
Number of shares received (in shares) | shares	1